Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization
Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide.
Arcinova announces major investment in Alnwick site with the installation of the R1000 capsule fill machine from 3P Innovation
Arcinova, a Quotient Sciences business, announces major investment in Alnwick site with the installation of the R1000 capsule fill machine from 3P Innovation
CPhI Pharma Award Winner- Arcinova- Flowinova Project
Exciting news - Arcinova, a Quotient Sciences business, has won the CPhI Pharma Award for Excellence in Pharma: Contract Services & Oursourcing for our Flowinova Project
Quotient Sciences Recognized as Top Pharma and Life Sciences Outsourcing Company
Quotient Sciences, a global drug development and manufacturing organization has been recognized as a “Top Pharma and Life Sciences Outsourcing Services Company in the UK for 2020” by PharmaTech Outlook magazine.
Arcinova increases LC-MS/MS capability with addition of SCIEX 6600 Triple TOF Mass Spectrometer
Arcinova, a Quotient Sciences business, purchased the Sciex 6600 T-TOF system equipped with an Exion LC front end and Sciex BioTool software to dramatically increase its capability for not only the quantitation of large biological molecules, but also their confirmation and characterization.